EPISODE · Dec 2, 2022 · 20 MIN
NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio
from NutraIngredients NutraCast · host William Reed Ltd
Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup and Ginkgo Bioworks spinoff Ayana Bio. At the helm of the company is Frank Jaksch, who previously spent over two decades leading publicly-traded ingredient company ChromaDex.
What this episode covers
Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup and Ginkgo Bioworks spinoff Ayana Bio. At the helm of the company is Frank Jaksch, who previously spent over two decades leading publicly-traded ingredient company ChromaDex.
NOW PLAYING
NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.